麦迪卫康(02159.HK)洽购香港寰宇医诚智慧科技发展100%股权
MEDIWELCOMEMEDIWELCOME(HK:02159) Ge Long Hui·2026-01-20 08:53

Core Viewpoint - The company, MediWecare (02159.HK), has signed a non-binding memorandum of understanding with a potential seller regarding the acquisition of 100% equity in Hong Kong Huanyu Medical Technology Development Co., Ltd. and its subsidiaries, which are collectively referred to as the "Target Group" [1] Group 1: Acquisition Details - The Target Group primarily provides artificial intelligence technology to global pharmaceutical and medical device companies [1] - The acquisition aims to enhance pharmaceutical research and physician training through innovative AI medical specialty models [1] - The Target Group utilizes Web3 core blockchain technology to ensure data authenticity, security, and traceability [1]